Modulators of cystic fibrosis transmembrane conductance regulator
US8598205B2 · kind B2 · utility
72Cited by
30References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 4, 2012 |
| Grant date | Dec 3, 2013 |
| Priority date | — |
| Expiry date | Apr 4, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/382
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to modulators of cystic fibrosis transmembrane conductance regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating diseases using modulators of CFTR.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.